Frailty consensus: a call to action
- PMID: 23764209
- PMCID: PMC4084863
- DOI: 10.1016/j.jamda.2013.03.022
Frailty consensus: a call to action
Abstract
Frailty is a clinical state in which there is an increase in an individual's vulnerability for developing increased dependency and/or mortality when exposed to a stressor. Frailty can occur as the result of a range of diseases and medical conditions. A consensus group consisting of delegates from 6 major international, European, and US societies created 4 major consensus points on a specific form of frailty: physical frailty. 1. Physical frailty is an important medical syndrome. The group defined physical frailty as "a medical syndrome with multiple causes and contributors that is characterized by diminished strength, endurance, and reduced physiologic function that increases an individual's vulnerability for developing increased dependency and/or death." 2. Physical frailty can potentially be prevented or treated with specific modalities, such as exercise, protein-calorie supplementation, vitamin D, and reduction of polypharmacy. 3. Simple, rapid screening tests have been developed and validated, such as the simple FRAIL scale, to allow physicians to objectively recognize frail persons. 4. For the purposes of optimally managing individuals with physical frailty, all persons older than 70 years and all individuals with significant weight loss (>5%) due to chronic disease should be screened for frailty.
Copyright © 2013 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Comment in
-
What is missing in the validation of frailty instruments?J Am Med Dir Assoc. 2014 Feb;15(2):141-2. doi: 10.1016/j.jamda.2013.11.007. Epub 2014 Jan 7. J Am Med Dir Assoc. 2014. PMID: 24405640 No abstract available.
-
Response to the letter to the editor: "Frailty consensus: a call to action".J Am Med Dir Assoc. 2014 Feb;15(2):142-3. doi: 10.1016/j.jamda.2013.11.011. J Am Med Dir Assoc. 2014. PMID: 24461242 Free PMC article. No abstract available.
-
Response to the letter to the editor: "What is missing in the validation of frailty instruments?".J Am Med Dir Assoc. 2014 Feb;15(2):143-4. doi: 10.1016/j.jamda.2013.11.012. J Am Med Dir Assoc. 2014. PMID: 24461243 No abstract available.
-
Response to the letter to the editor: "Frailty consensus: a call to action".J Am Med Dir Assoc. 2014 Feb;15(2):145-7. doi: 10.1016/j.jamda.2013.11.015. J Am Med Dir Assoc. 2014. PMID: 24461245 No abstract available.
-
Response to the letter to the editor entitled "What is missing in the validation of frailty instruments?" by Drs Xue and Varadhan: The Toulouse frailty clinic, 1 year of clinical experience.J Am Med Dir Assoc. 2014 Feb;15(2):147-9. doi: 10.1016/j.jamda.2013.11.021. J Am Med Dir Assoc. 2014. PMID: 24461246 No abstract available.
-
Response to the letter to the editor from Xue and Varadhan titled "What is missing in the validation of frailty instruments?".J Am Med Dir Assoc. 2014 Feb;15(2):147. doi: 10.1016/j.jamda.2013.11.014. J Am Med Dir Assoc. 2014. PMID: 24461247 No abstract available.
References
-
- Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc. 2006;54:991–1001. - PubMed
-
- Cerreta F, Eichler HG, Rasi G. Drug policy for an aging population—the European Medicines Agency’s geriatric medicines strategy. N Engl J Med. 2012;367:1972–1974. - PubMed
-
- [Accessed April 22, 2013]; Available at: http://ec.europa.eu/economy_finance/publications/european_economy/2012/p....
-
- Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27:17–26. - PubMed
-
- Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59:255–263. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous